Pemetrexed monotherapy as salvage treatment in metastatic colorectal cancer patients who failed standard chemotherapy: A phase II single-arm prospective trial.

被引：0
|
作者：
Lim, Sung Won [1 ]
Cho, Jangho [1 ]
Lee, Jeeyun [1 ]
Park, Se Hoon [1 ]
Park, Joon Oh [1 ]
Park, Young Suk [1 ]
Lim, Ho Yeong [1 ]
Kang, Won Ki [1 ]
Kim, Seung Tae [1 ]
机构：
[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.840
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
840
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer
    Yamaguchi, Kazuhisa
    Taniguchi, Hiroya
    Komori, Azusa
    Narita, Yukiya
    Nitta, Sohei
    Nomura, Motoo
    Kadowaki, Shigenori
    Takahari, Daisuke
    Ura, Takashi
    Andoh, Masashi
    Muro, Kei
    Mori, Keita
    Igarashi, Yoshinori
    BMC CANCER, 2015, 15
  • [32] CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase Ⅱ trial
    Fangqi Liu
    Li Yang
    Yuchen Wu
    Cong Li
    Jiang Zhao
    Adili Keranmu
    Hongtu Zheng
    Dan Huang
    Lei Wang
    Tong Tong
    Junyan Xu
    Ji Zhu
    Sanjun Cai
    Ye Xu
    ChineseJournalofCancerResearch, 2016, 28 (06) : 589 - 597
  • [33] Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial.
    Wei, Wei
    Ban, Xiaohua
    Yang, Fan
    Huang, Yongwen
    Li, Jibin
    Qiu, Ya
    Cheng, Xiaqin
    Li, Jundong
    Zheng, Min
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] Anlotinib in patients with recurrent advanced cervical cancer: A prospective single-arm, open-label, phase. trial.
    Wu, Xiaohua
    Zhu, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon cancer: A single-arm phase II trial.
    Meng, Wenjian
    Qiu, Meng
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 201 - 201
  • [36] Stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer: Updated findings from a single-arm, prospective phase II trial (RIFLE)
    Chen, Yajie
    Wang, Kun
    Zhang Zhiyuan
    Zhang, Hui
    Yang, Wang
    Wu, Ruiyan
    Zhou, Menglong
    Zhang, Zhen
    Xia, Fan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer: Preliminary findings from a single-arm, prospective phase II trial (RIFLE)
    Chen, Y.
    Wang, K.
    Zhiyuan, Z.
    Zhang, H.
    Yang, W.
    Wu, R.
    Zhou, M.
    Zhang, Z.
    Xia, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S451 - S451
  • [38] Stereotactic Ablative Radiotherapy Combined with Fruquintinib and Tislelizumab in Metastatic Colorectal Cancer: Updated Findings from a Single-Arm, Prospective Phase II Trial (RIFLE)
    Chen, Y.
    Wang, K.
    Zhang, Z.
    Zhang, H.
    Yang, W.
    Wu, R.
    Zhou, M.
    Zhang, Z.
    Xia, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E432 - E433
  • [39] Stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer: Updated findings from a single-arm, prospective phase II trial (RIFLE)
    Chen, Y.
    Wang, K.
    Zhang, Z.
    Zhang, H.
    Yang, W.
    Wu, R.
    Zhou, M.
    Zhang, Z.
    Xia, F.
    ANNALS OF ONCOLOGY, 2024, 35 : S449 - S449
  • [40] Apatinib monotherapy for chemotherapy-refractory metastatic colorectal cancer: A multicenter, single arm, prospective study.
    Wang, Fen
    Wang, Shubin
    Yuan, Xia
    Jia, Jun
    Bi, Xiaoxia
    Zhou, Zeqiang
    Zhou, Qiming
    Luo, Changguo
    Deng, Minghui
    Yi, Liangjie
    Li, Yong
    Li, Xia
    Lu, Jianxin
    Su, Wenzhi
    Chen, Hanbin
    Zhu, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345